{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:13:47Z","timestamp":1791508427172,"version":"4.3.4"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,27]]},"DOI":"10.7759\/cureus.18327","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T14:10:13Z","timestamp":1632751813000},"source":"Crossref","is-referenced-by-count":9,"title":["Dermatologic Manifestations of Endocrine Disorders"],"prefix":"10.7759","author":[{"given":"Rishi","family":"Raj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada","family":"Elshimy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nivedita","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vismaya","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Bratman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sri Harsha","family":"Tella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200304050-00003","article-title":"Cutaneous manifestations of endocrine disorders: a guide for dermatologists","volume":"4","author":"Jabbour SA","year":"2003","unstructured":"Jabbour SA. Cutaneous manifestations of endocrine disorders: a guide for dermatologists. Am J Clin Dermatol. 2003, 4:315-31. 10.2165\/00128071-200304050-00003","journal-title":"Am J Clin Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2011.10.001","article-title":"Thyroid dermopathy and acropachy","volume":"26","author":"Fatourechi V","year":"2012","unstructured":"Fatourechi V. Thyroid dermopathy and acropachy. Best Pract Res Clin Endocrinol Metab. 2012, 26:553-65. 10.1016\/j.beem.2011.10.001","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4161\/19381980.2014.981078","article-title":"Thyroid dermopathy-a diagnostic clue of hidden hyperthyroidism","volume":"6","author":"Dhali TK","year":"2014","unstructured":"Dhali TK, Chahar M. Thyroid dermopathy-a diagnostic clue of hidden hyperthyroidism. Dermatoendocrinol. 2014, 6:e981078. 10.4161\/19381980.2014.981078","journal-title":"Dermatoendocrinol"},{"key":"ref4","article-title":"Palmar telangiectases as a manifestation of Graves disease","volume":"89","author":"Nabatian A","year":"2012","unstructured":"Nabatian A, Suchter MF, Milgraum S. Palmar telangiectases as a manifestation of Graves disease. Cutis. 2012, 89:84-8.","journal-title":"Cutis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1272\/jnms.81.106","article-title":"Hashimoto's thyroiditis with clinical manifestations resembling dermatomyositis: a case report","volume":"81","author":"Matayoshi T","year":"2014","unstructured":"Matayoshi T, Omi T, Mayumi N, Kawana S. Hashimoto's thyroiditis with clinical manifestations resembling dermatomyositis: a case report. J Nippon Med Sch. 2014, 81:106-9. 10.1272\/jnms.81.106","journal-title":"J Nippon Med Sch"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.9906","article-title":"Erythema annulare centrifugum: a rare skin manifestation of Hashimoto thyroiditis","volume":"12","author":"Jalil P","year":"2020","unstructured":"Jalil P, Masood S, Fatima S. Erythema annulare centrifugum: a rare skin manifestation of Hashimoto thyroiditis. Cureus. 2020, 12:e9906. 10.7759\/cureus.9906","journal-title":"Cureus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4161\/derm.3.3.17027","article-title":"Thyroid hormone action on skin","volume":"3","author":"Safer JD","year":"2011","unstructured":"Safer JD. Thyroid hormone action on skin. Dermatoendocrinol. 2011, 3:211-5. 10.4161\/derm.3.3.17027","journal-title":"Dermatoendocrinol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-200105000-00003","article-title":"The glucagonoma syndrome: a review of its features and discussion of new perspectives","volume":"321","author":"Chastain MA","year":"2001","unstructured":"Chastain MA. The glucagonoma syndrome: a review of its features and discussion of new perspectives. Am J Med Sci. 2001, 321:306-20. 10.1097\/00000441-200105000-00003","journal-title":"Am J Med Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13752","article-title":"Glucagonoma syndrome: a review and update on treatment","volume":"30","author":"John AM","year":"2016","unstructured":"John AM, Schwartz RA. Glucagonoma syndrome: a review and update on treatment. J Eur Acad Dermatol Venereol. 2016, 30:2016-22. 10.1111\/jdv.13752","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker RV","year":"2012","unstructured":"Thakker RV, Newey PJ, Walls GV, et al.. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab. 2012, 97:2990-3011. 10.1210\/jc.2012-1230","journal-title":"J Clin Endocrinol Metab"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-016-0708-1","article-title":"MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients","volume":"14","author":"de Laat JM","year":"2016","unstructured":"de Laat JM, van der Luijt RB, Pieterman CR, et al.. MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients. BMC Med. 2016, 14:182. 10.1186\/s12916-016-0708-1","journal-title":"BMC Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-016-9401-0","article-title":"Hereditary syndromes predisposing to endocrine tumors and their skin manifestations","volume":"17","author":"Stratakis CA","year":"2016","unstructured":"Stratakis CA. Hereditary syndromes predisposing to endocrine tumors and their skin manifestations. Rev Endocr Metab Disord. 2016, 17:381-8. 10.1007\/s11154-016-9401-0","journal-title":"Rev Endocr Metab Disord"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0218","article-title":"Cutaneous tumors in patients with multiple endocrine neoplasm type 1 (MEN1) and gastrinomas: prospective study of frequency and development of criteria with high sensitivity and specificity for MEN1","volume":"89","author":"Asgharian B","year":"2004","unstructured":"Asgharian B, Turner ML, Gibril F, Entsuah LK, Serrano J, Jensen RT. Cutaneous tumors in patients with multiple endocrine neoplasm type 1 (MEN1) and gastrinomas: prospective study of frequency and development of criteria with high sensitivity and specificity for MEN1. J Clin Endocrinol Metab. 2004, 89:5328-36. 10.1210\/jc.2004-0218","journal-title":"J Clin Endocrinol Metab"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.1997.03890430067009","article-title":"Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1","volume":"133","author":"Darling TN","year":"1997","unstructured":"Darling TN, Skarulis MC, Steinberg SM, Marx SJ, Spiegel AM, Turner M. Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1. Arch Dermatol. 1997, 133:853-7.","journal-title":"Arch Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.97679","article-title":"Not just skin deep: a case report of multiple endocrine neoplasia type 1","volume":"57","author":"Simi S","year":"2012","unstructured":"Simi S, Narayanan B, Nandakumar G. Not just skin deep: a case report of multiple endocrine neoplasia type 1. Indian J Dermatol. 2012, 57:304-7. 10.4103\/0019-5154.97679","journal-title":"Indian J Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/363458a0","article-title":"Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A","volume":"363","author":"Mulligan LM","year":"1993","unstructured":"Mulligan LM, Kwok JB, Healey CS, et al.. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature. 1993, 363:458-60. 10.1038\/363458a0","journal-title":"Nature"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-016-9892-6","article-title":"MEN 2A-related cutaneous lichen amyloidosis: report of three kindred and systematic literature review of clinical, biochemical and molecular characteristics","volume":"15","author":"Scapineli JO","year":"2016","unstructured":"Scapineli JO, Ceolin L, Pu\u00f1ales MK, Dora JM, Maia AL. MEN 2A-related cutaneous lichen amyloidosis: report of three kindred and systematic literature review of clinical, biochemical and molecular characteristics. Fam Cancer. 2016, 15:625-33. 10.1007\/s10689-016-9892-6","journal-title":"Fam Cancer"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2010.22.4.452","article-title":"Multiple endocrine neoplasia type 2B: early diagnosis by multiple mucosal neuroma and its DNA analysis","volume":"22","author":"Lee MJ","year":"2010","unstructured":"Lee MJ, Chung KH, Park JS, Chung H, Jang HC, Kim JW. Multiple endocrine neoplasia type 2B: early diagnosis by multiple mucosal neuroma and its DNA analysis. Ann Dermatol. 2010, 22:452-5. 10.5021\/ad.2010.22.4.452","journal-title":"Ann Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/s0960-7404(00)00038-4","article-title":"Multiple endocrine neoplasia type 2B--genetic basis and clinical expression","volume":"9","author":"Lee NC","year":"2000","unstructured":"Lee NC, Norton JA. Multiple endocrine neoplasia type 2B--genetic basis and clinical expression. Surg Oncol. 2000, 9:111-8. 10.1016\/s0960-7404(00)00038-4","journal-title":"Surg Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.3959","article-title":"Dermal hyperneury and multiple sclerotic fibromas in multiple endocrine neoplasia type 2A syndrome","volume":"153","author":"Alegr\u00eda-Landa V","year":"2017","unstructured":"Alegr\u00eda-Landa V, Jo-Velasco M, Robledo M, Requena L. Dermal hyperneury and multiple sclerotic fibromas in multiple endocrine neoplasia type 2A syndrome. JAMA Dermatol. 2017, 153:1298-301. 10.1001\/jamadermatol.2017.3959","journal-title":"JAMA Dermatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20389","article-title":"Comprehensive NF1 screening on cultured Schwann cells from neurofibromas","volume":"27","author":"Maertens O","year":"2006","unstructured":"Maertens O, Brems H, Vandesompele J, et al.. Comprehensive NF1 screening on cultured Schwann cells from neurofibromas. Hum Mutat. 2006, 27:1030-40. 10.1002\/humu.20389","journal-title":"Hum Mutat"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1086\/504441","article-title":"Double inactivation of NF1 in tibial pseudarthrosis","volume":"79","author":"Stevenson DA","year":"2006","unstructured":"Stevenson DA, Zhou H, Ashrafi S, et al.. Double inactivation of NF1 in tibial pseudarthrosis. Am J Hum Genet. 2006, 79:143-8. 10.1086\/504441","journal-title":"Am J Hum Genet"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13030463","article-title":"Cutaneous findings in neurofibromatosis type 1","volume":"13","author":"Ozarslan B","year":"2021","unstructured":"Ozarslan B, Russo T, Argenziano G, Santoro C, Piccolo V. Cutaneous findings in neurofibromatosis type 1. Cancers (Basel). 2021, 13:463. 10.3390\/cancers13030463","journal-title":"Cancers (Basel)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1159\/000369802","article-title":"Endocrine implications of neurofibromatosis 1 in childhood","volume":"83","author":"Bizzarri C","year":"2015","unstructured":"Bizzarri C, Bottaro G. Endocrine implications of neurofibromatosis 1 in childhood. Horm Res Paediatr. 2015, 83:232-41. 10.1159\/000369802","journal-title":"Horm Res Paediatr"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-3204","article-title":"Neurofibromatosis type 1 revisited","volume":"123","author":"Williams VC","year":"2009","unstructured":"Williams VC, Lucas J, Babcock MA, Gutmann DH, Korf B, Maria BL. Neurofibromatosis type 1 revisited. Pediatrics. 2009, 123:124-33. 10.1542\/peds.2007-3204","journal-title":"Pediatrics"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1177\/088307380201700806","article-title":"Clinical features and pathobiology of neurofibromatosis 1","volume":"17","author":"Korf BR","year":"2002","unstructured":"Korf BR. Clinical features and pathobiology of neurofibromatosis 1. J Child Neurol. 2002, 17:573-7; discussion 602-4, 646-51. 10.1177\/088307380201700806","journal-title":"J Child Neurol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.12.051","article-title":"Neurofibromatosis type 1","volume":"61","author":"Boyd KP","year":"2009","unstructured":"Boyd KP, Korf BR, Theos A. Neurofibromatosis type 1. J Am Acad Dermatol. 2009, 61:1-14; quiz 15-6. 10.1016\/j.jaad.2008.12.051","journal-title":"J Am Acad Dermatol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004575","article-title":"Genetic modifiers of neurofibromatosis type 1-associated caf\u00e9-au-lait macule count identified using multi-platform analysis","volume":"10","author":"Pemov A","year":"2014","unstructured":"Pemov A, Sung H, Hyland PL, et al.. Genetic modifiers of neurofibromatosis type 1-associated caf\u00e9-au-lait macule count identified using multi-platform analysis. PLoS Genet. 2014, 10:e1004575. 10.1371\/journal.pgen.1004575","journal-title":"PLoS Genet"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.05.061","article-title":"Role of VHL gene mutation in human cancer","volume":"22","author":"Kim WY","year":"2004","unstructured":"Kim WY, Kaelin WG. Role of VHL gene mutation in human cancer. J Clin Oncol. 2004, 22:4991-5004. 10.1200\/JCO.2004.05.061","journal-title":"J Clin Oncol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M503220200","article-title":"Tumor suppression by the von Hippel-Lindau protein requires phosphorylation of the acidic domain","volume":"280","author":"Lolkema MP","year":"2005","unstructured":"Lolkema MP, Gervais ML, Snijckers CM, Hill RP, Giles RH, Voest EE, Ohh M. Tumor suppression by the von Hippel-Lindau protein requires phosphorylation of the acidic domain. J Biol Chem. 2005, 280:22205-11. 10.1074\/jbc.M503220200","journal-title":"J Biol Chem"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1038\/ncb1912","article-title":"VHL loss causes spindle misorientation and chromosome instability","volume":"11","author":"Thoma CR","year":"2009","unstructured":"Thoma CR, Toso A, Gutbrodt KL, et al.. VHL loss causes spindle misorientation and chromosome instability. Nat Cell Biol. 2009, 11:994-1001. 10.1038\/ncb1912","journal-title":"Nat Cell Biol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-200101000-00009","article-title":"Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease","volume":"48","author":"Conway JE","year":"2001","unstructured":"Conway JE, Chou D, Clatterbuck RE, Brem H, Long DM, Rigamonti D. Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease. Neurosurgery. 2001, 48:55-62; discussion 62-3. 10.1097\/00006123-200101000-00009","journal-title":"Neurosurgery"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13643-4","article-title":"von Hippel-Lindau disease","volume":"361","author":"Lonser RR","year":"2003","unstructured":"Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM, Oldfield EH. von Hippel-Lindau disease. Lancet. 2003, 361:2059-67. 10.1016\/S0140-6736(03)13643-4","journal-title":"Lancet"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000203645.25173.70","article-title":"Clinical findings of the phakomatoses: neurofibromatosis","volume":"66","author":"Quigg M","year":"2006","unstructured":"Quigg M, Rust RS, Miller JQ. Clinical findings of the phakomatoses: neurofibromatosis. Neurology. 2006, 66:E23-4. 10.1212\/01.wnl.0000203645.25173.70","journal-title":"Neurology"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.136.7.769","article-title":"Von Hippel-Lindau disease: clinical and pathological manifestations in nine families with 50 affected members","volume":"136","author":"Horton WA","year":"1976","unstructured":"Horton WA, Wong V, Eldridge R. Von Hippel-Lindau disease: clinical and pathological manifestations in nine families with 50 affected members. Arch Intern Med. 1976, 136:769-77. 10.1001\/archinte.136.7.769","journal-title":"Arch Intern Med"},{"key":"ref36","article-title":"Pseudohypoaldosteronism type II","author":"Ellison DH","year":"2017","unstructured":"Ellison DH. Pseudohypoaldosteronism type II. GeneReviews, Seattle, WA; 2017."},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010050457","article-title":"Mechanisms of type I and type II pseudohypoaldosteronism","volume":"21","author":"Furgeson SB","year":"2010","unstructured":"Furgeson SB, Linas S. Mechanisms of type I and type II pseudohypoaldosteronism. J Am Soc Nephrol. 2010, 21:1842-5. 10.1681\/ASN.2010050457","journal-title":"J Am Soc Nephrol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2014-203741","article-title":"Ocular and skin manifestations in systemic pseudohypoaldosteronism","volume":"2014","author":"Eliwa MS","year":"2014","unstructured":"Eliwa MS, El-Emmawie AH, Saeed MA. Ocular and skin manifestations in systemic pseudohypoaldosteronism. BMJ Case Rep. 2014, 2014:bcr2014203741. 10.1136\/bcr-2014-203741","journal-title":"BMJ Case Rep"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3109\/09537104.2011.641624","article-title":"Miliaria rubra and thrombocytosis in pseudohypoaldosteronism: case report","volume":"23","author":"Onal H","year":"2012","unstructured":"Onal H, Adal E, Ersen A, Onal Z, Keskindemirci G. Miliaria rubra and thrombocytosis in pseudohypoaldosteronism: case report. Platelets. 2012, 23:645-7. 10.3109\/09537104.2011.641624","journal-title":"Platelets"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.4274\/jcrpe.1740","article-title":"Dermal and ophthalmic findings in pseudohypoaldosteronism","volume":"7","author":"Korkut S","year":"2015","unstructured":"Korkut S, G\u00f6kalp E, \u00d6zdemir A, Kurto\u011flu S, Demirta\u015f \u015e, G\u00fcl \u00dc, Ba\u015ftu\u011f O. Dermal and ophthalmic findings in pseudohypoaldosteronism. J Clin Res Pediatr Endocrinol. 2015, 7:155-8. 10.4274\/jcrpe.1740","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2006.04.003","article-title":"Dermatologic manifestations of parathyroid-related disorders","volume":"24","author":"Fuleihan Gel-H","year":"2006","unstructured":"Fuleihan Gel-H, Rubeiz N. Dermatologic manifestations of parathyroid-related disorders. Clin Dermatol. 2006, 24:281-8. 10.1016\/j.clindermatol.2006.04.003","journal-title":"Clin Dermatol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00530108","article-title":"Calciphylaxis from nonuremic causes: a systematic review","volume":"3","author":"Nigwekar SU","year":"2008","unstructured":"Nigwekar SU, Wolf M, Sterns RH, Hix JK. Calciphylaxis from nonuremic causes: a systematic review. Clin J Am Soc Nephrol. 2008, 3:1139-43. 10.2215\/CJN.00530108","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.9.7903","article-title":"Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation","volume":"86","author":"Stratakis CA","year":"2001","unstructured":"Stratakis CA, Kirschner LS, Carney JA. Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab. 2001, 86:4041-6. 10.1210\/jcem.86.9.7903","journal-title":"J Clin Endocrinol Metab"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2333","article-title":"Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes","volume":"94","author":"Bertherat J","year":"2009","unstructured":"Bertherat J, Horvath A, Groussin L, et al.. Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes. J Clin Endocrinol Metab. 2009, 94:2085-91. 10.1210\/jc.2008-2333","journal-title":"J Clin Endocrinol Metab"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2010.03.003","article-title":"Clinical and molecular genetics of Carney complex","volume":"24","author":"Rothenbuhler A","year":"2010","unstructured":"Rothenbuhler A, Stratakis CA. Clinical and molecular genetics of Carney complex. Best Pract Res Clin Endocrinol Metab. 2010, 24:389-99. 10.1016\/j.beem.2010.03.003","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1096-8628(19981102)80:2<183::aid-ajmg19>3.0.co;2-i","article-title":"Carney complex: diagnosis and management of the complex of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas","volume":"80","author":"Stratakis CA","year":"1998","unstructured":"Stratakis CA, Kirschner LS, Carney JA. Carney complex: diagnosis and management of the complex of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas. Am J Med Genet. 1998, 80:183-5. 10.1002\/(sici)1096-8628(19981102)80:2&lt;183::aid-ajmg19&gt;3.0.co;2-i","journal-title":"Am J Med Genet"},{"key":"ref47","article-title":"Epithelioid blue nevus and psammomatous melanotic schwannoma: the unusual pigmented skin tumors of the Carney complex","volume":"15","author":"Carney JA","year":"1998","unstructured":"Carney JA, Stratakis CA. Epithelioid blue nevus and psammomatous melanotic schwannoma: the unusual pigmented skin tumors of the Carney complex. Semin Diagn Pathol. 1998, 15:216-24.","journal-title":"Semin Diagn Pathol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199603000-00001","article-title":"The epithelioid blue nevus. A multicentric familial tumor with important associations, including cardiac myxoma and psammomatous melanotic schwannoma","volume":"20","author":"Carney JA","year":"1996","unstructured":"Carney JA, Ferreiro JA. The epithelioid blue nevus. A multicentric familial tumor with important associations, including cardiac myxoma and psammomatous melanotic schwannoma. Am J Surg Pathol. 1996, 20:259-72. 10.1097\/00000478-199603000-00001","journal-title":"Am J Surg Pathol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(05)70244-8","article-title":"Clinical phenotypes and molecular genetic mechanisms of Carney complex","volume":"6","author":"Wilkes D","year":"2005","unstructured":"Wilkes D, McDermott DA, Basson CT. Clinical phenotypes and molecular genetic mechanisms of Carney complex. Lancet Oncol. 2005, 6:501-8. 10.1016\/S1470-2045(05)70244-8","journal-title":"Lancet Oncol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2011.04292.x","article-title":"Linear skin atrophy preceding calcinosis cutis in pseudo-pseudohypoparathyroidism","volume":"37","author":"Lau K","year":"2012","unstructured":"Lau K, Willig RP, Hiort O, Hoeger PH. Linear skin atrophy preceding calcinosis cutis in pseudo-pseudohypoparathyroidism. Clin Exp Dermatol. 2012, 37:646-8. 10.1111\/j.1365-2230.2011.04292.x","journal-title":"Clin Exp Dermatol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198007000-00006","article-title":"Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature","volume":"59","author":"Bardwick PA","year":"1980","unstructured":"Bardwick PA, Zvaifler NJ, Gill GN, Newman D, Greenway GD, Resnick DL. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature. Medicine (Baltimore). 1980, 59:311-22. 10.1097\/00005792-198007000-00006","journal-title":"Medicine (Baltimore)"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1159\/000381302","article-title":"Cutaneous manifestations in POEMS syndrome: case report and review","volume":"7","author":"Marinho FS","year":"2015","unstructured":"Marinho FS, Pirmez R, Nogueira R, Cuzzi T, Sodr\u00e9 CT, Ramos-e-Silva M. Cutaneous manifestations in POEMS syndrome: case report and review. Case Rep Dermatol. 2015, 7:61-9. 10.1159\/000381302","journal-title":"Case Rep Dermatol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23288","article-title":"POEMS syndrome: update on diagnosis, risk-stratification, and management","volume":"87","author":"Dispenzieri A","year":"2012","unstructured":"Dispenzieri A. POEMS syndrome: update on diagnosis, risk-stratification, and management. Am J Hematol. 2012, 87:804-14. 10.1002\/ajh.23288","journal-title":"Am J Hematol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13378","article-title":"Clinical and laboratory characterization of 114 cases of Castleman disease patients from a single centre: paraneoplastic pemphigus is an unfavourable prognostic factor","volume":"169","author":"Dong Y","year":"2015","unstructured":"Dong Y, Wang M, Nong L, et al.. Clinical and laboratory characterization of 114 cases of Castleman disease patients from a single centre: paraneoplastic pemphigus is an unfavourable prognostic factor. Br J Haematol. 2015, 169:834-42. 10.1111\/bjh.13378","journal-title":"Br J Haematol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.37.11.828","article-title":"Will the real Cowden syndrome please stand up: revised diagnostic criteria","volume":"37","author":"Eng C","year":"2000","unstructured":"Eng C. Will the real Cowden syndrome please stand up: revised diagnostic criteria. J Med Genet. 2000, 37:828-30. 10.1136\/jmg.37.11.828","journal-title":"J Med Genet"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejhg.5200289","article-title":"Novel PTEN mutations in patients with Cowden disease: absence of clear genotype-phenotype correlations","volume":"7","author":"Nelen MR","year":"1999","unstructured":"Nelen MR, Kremer H, Konings IB, et al.. Novel PTEN mutations in patients with Cowden disease: absence of clear genotype-phenotype correlations. Eur J Hum Genet. 1999, 7:267-73. 10.1038\/sj.ejhg.5200289","journal-title":"Eur J Hum Genet"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e3181ac9aea","article-title":"PTEN hamartoma tumor syndrome: an overview","volume":"11","author":"Hobert JA","year":"2009","unstructured":"Hobert JA, Eng C. PTEN hamartoma tumor syndrome: an overview. Genet Med. 2009, 11:687-94. 10.1097\/GIM.0b013e3181ac9aea","journal-title":"Genet Med"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30053-8","article-title":"Hypopituitarism","volume":"388","author":"Higham CE","year":"2016","unstructured":"Higham CE, Johannsson G, Shalet SM. Hypopituitarism. Lancet. 2016, 388:2403-15. 10.1016\/S0140-6736(16)30053-8","journal-title":"Lancet"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61126-5","article-title":"Male hypogonadism","volume":"383","author":"Basaria S","year":"2014","unstructured":"Basaria S. Male hypogonadism. Lancet. 2014, 383:1250-63. 10.1016\/S0140-6736(13)61126-5","journal-title":"Lancet"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.83.2.4594","article-title":"Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee","volume":"83","author":"Carroll PV","year":"1998","unstructured":"Carroll PV, Christ ER, Bengtsson BA, et al.. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab. 1998, 83:382-95. 10.1210\/jcem.83.2.4594","journal-title":"J Clin Endocrinol Metab"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(14)70142-1","article-title":"Diagnosis and management of adrenal insufficiency","volume":"3","author":"Bancos I","year":"2015","unstructured":"Bancos I, Hahner S, Tomlinson J, Arlt W. Diagnosis and management of adrenal insufficiency. Lancet Diabetes Endocrinol. 2015, 3:216-26. 10.1016\/S2213-8587(14)70142-1","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.58.685.690","article-title":"Patients presenting with Addison's disease need not be pigmented","volume":"58","author":"Barnett AH","year":"1982","unstructured":"Barnett AH, Espiner EA, Donald RA. Patients presenting with Addison's disease need not be pigmented. Postgrad Med J. 1982, 58:690-2. 10.1136\/pgmj.58.685.690","journal-title":"Postgrad Med J"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1368","article-title":"Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry","volume":"94","author":"Erichsen MM","year":"2009","unstructured":"Erichsen MM, L\u00f8v\u00e5s K, Skinningsrud B, et al.. Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J Clin Endocrinol Metab. 2009, 94:4882-90. 10.1210\/jc.2009-1368","journal-title":"J Clin Endocrinol Metab"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2003.9936","article-title":"Waterhouse-Friderichsen syndrome as a result of non-meningococcal infection","volume":"57","author":"Hamilton D","year":"2004","unstructured":"Hamilton D, Harris MD, Foweraker J, Gresham GA. Waterhouse-Friderichsen syndrome as a result of non-meningococcal infection. J Clin Pathol. 2004, 57:208-9. 10.1136\/jcp.2003.9936","journal-title":"J Clin Pathol"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.88782","article-title":"Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy","volume":"1","author":"Ferre EM","year":"2016","unstructured":"Ferre EM, Rose SR, Rosenzweig SD, et al.. Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. JCI Insight. 2016, 1:10.1172\/jci.insight.88782","journal-title":"JCI Insight"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-015-0176-y","article-title":"Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy","volume":"35","author":"Kisand K","year":"2015","unstructured":"Kisand K, Peterson P. Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy. J Clin Immunol. 2015, 35:463-78. 10.1007\/s10875-015-0176-y","journal-title":"J Clin Immunol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2006.07.010","article-title":"X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetic aspects","volume":"1763","author":"Berger J","year":"2006","unstructured":"Berger J, G\u00e4rtner J. X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetic aspects. Biochim Biophys Acta. 2006, 1763:1721-32. 10.1016\/j.bbamcr.2006.07.010","journal-title":"Biochim Biophys Acta"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000133625.73570.54","article-title":"Clinical course of genetic diseases of the insulin receptor (type A and Rabson-Mendenhall syndromes): a 30-year prospective","volume":"83","author":"Musso C","year":"2004","unstructured":"Musso C, Cochran E, Moran SA, Skarulis MC, Oral EA, Taylor S, Gorden P. Clinical course of genetic diseases of the insulin receptor (type A and Rabson-Mendenhall syndromes): a 30-year prospective. Medicine (Baltimore). 2004, 83:209-22. 10.1097\/01.md.0000133625.73570.54","journal-title":"Medicine (Baltimore)"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.75.11.772","article-title":"Skin manifestations of diabetes","volume":"75","author":"Van Hattem S","year":"2008","unstructured":"Van Hattem S, Bootsma AH, Thio HB. Skin manifestations of diabetes. Cleve Clin J Med. 2008, 75:772, 774, 776-7 passim. 10.3949\/ccjm.75.11.772","journal-title":"Cleve Clin J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/72488-dermatologic-manifestations-of-endocrine-disorders","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:19Z","timestamp":1707507259000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/72488-dermatologic-manifestations-of-endocrine-disorders"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,27]]},"references-count":69,"URL":"https:\/\/doi.org\/10.7759\/cureus.18327","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,27]]}}}